PHI with Renal diabetes insipidus
How does this condition affect your private health insurance?
Diabetes insipidus renalis, or nephrogenic diabetes insipidus, is a rare kidney disorder where the renal tubules cannot respond effectively to vasopressin (ADH), leading to an inability to concentrate urine. This results in excessive urine production (polyuria) and compensatory extreme thirst (polydipsia). It's distinct from diabetes mellitus as it does not involve blood sugar regulation. Causes can be genetic (often X-linked) or acquired due to certain medications like lithium, chronic kidney disease, or severe electrolyte imbalances such as hypercalcemia or hypokalemia. If fluid intake is insufficient, dehydration and dangerous electrolyte disturbances, particularly hypernatremia, can develop. Management focuses on maintaining adequate hydration and addressing underlying causes.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months, or acute onset in acquired forms.
Duration of Illness (Lifetime)
Chronic, lifelong condition.
Cost of Treatment (Initial)
Moderate, involving diagnostic tests and initial management.
Cost of Treatment (Lifetime)
Moderate to high, due to lifelong management, medication, and regular monitoring.
Mortality Rate
Very low, if properly managed; higher if untreated severe dehydration and electrolyte imbalance occur.
Risk of Secondary Damages
High (dehydration, severe electrolyte imbalances, potential kidney damage if poorly managed).
Probability of Full Recovery
Very low for inherited forms; possible but not guaranteed for acquired forms if the underlying cause is reversible and promptly addressed.
Underlying Disease Risk
Varies; genetic mutations in inherited forms; acquired forms may be associated with chronic kidney disease, hypercalcemia, hypokalemia, or medication side effects (e.g., lithium).